Pronova BioPharma Overview

  • Founded
  • 1837
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 154
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

Pronova BioPharma General Information

Description

Developer lipid therapies. The company develops and manufactures marine originated omega-3 derived pharmaceutical products.

Contact Information

Website
basf.no
Formerly Known As
Pronova Biocare
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
BASF
Primary Office
  • Vollsveien 6
  • 1366 Oslo
  • Norway
+47 22 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pronova BioPharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pronova BioPharma‘s full profile, request access.

Request a free trial

Pronova BioPharma Executive Team (3)

Name Title Board Seat Contact Info
Morten Jurs Chief Executive Officer
To view Pronova BioPharma’s complete executive team members history, request access »

Pronova BioPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pronova BioPharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pronova BioPharma‘s full profile, request access.

Request a free trial